Biography and Research Information
OverviewAI-generated summary
Prabhat Singh Malik's research focuses on various aspects of cancer, with a particular emphasis on lung cancer and its management. His work has explored the assessment of brain metastasis in non-small-cell lung cancer through prospective observational studies, as well as the expression and clinical relevance of specific microRNAs as biomarkers in lung cancer. Malik has also investigated treatment strategies, including neoadjuvant Osimertinib for resectable EGFR-mutated non-small cell lung cancer and Pazopanib-based oral metronomic therapy for platinum-resistant epithelial ovarian cancer. His research extends to understanding the impact of comorbidities on disease severity, as demonstrated by a study on the detrimental effects of diabetes and hypertension on COVID-19 infection severity and mortality in India.
Additionally, Malik has been involved in developing national cancer databases for cost and quality of life assessments in India. His publication record includes studies on cancer in India, topical diclofenac for the prevention of capecitabine-associated hand-foot syndrome, and the development of national cancer databases. With an h-index of 22 and over 226 publications, his work has garnered significant citations. Malik is designated as a high-impact, highly cited researcher and remains actively engaged in research, with recent publications extending to 2025.
Metrics
- h-index: 22
- Publications: 222
- Citations: 1,909
Selected Publications
-
Combination chemotherapy with gefitinib as first-line treatment in EGFR-mutated metastatic non-small cell lung cancer: A retrospective Indian experience (2025)
-
Recent Advances in the Management of EGFR-Mutated Advanced Non-Small Cell Lung Cancer—A Narrative Review (2025)
-
Neoadjuvant Osimertinib for Resectable <i>EGFR</i> -Mutated Non–Small Cell Lung Cancer (2025)
-
Young Onset Lung Cancer in India: Insights Into Clinical, Demographic, and Genomic Profiles (2025)
-
Concurrent hypoxia and apoptosis imparts immune programming potential in mesenchymal stem cells: Lesson from acute graft-versus-host-disease model (2024)
-
Integrating Artificial Intelligence-Driven Wearable Technology in Oncology Decision-Making: A Narrative Review (2024)
-
Landscape of Clinically Relevant Genomic Alterations in the Indian Non-small Cell Lung Cancer Patients (2024)
-
Pleural effusion supernatant: a reliable resource for cell-free DNA in molecular testing of lung cancer (2024)
-
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial (2024)
-
Retrospective application of WHO reporting system for lung cytopathology with assessment of risk of malignancy (2024)
-
SMART-ESAS: Smartphone Monitoring and Assessment in Real Time of Edmonton Symptom Assessment System Scores for Patients With Cancer (2024)
-
Concordance of Immunohistochemistry and Fluorescence In Situ Hybridization in the Detection of Anaplastic Lymphoma Kinase ( <i>ALK</i> ) and Ros Proto-oncogene 1 ( <i>ROS1</i> ) Gene Rearrangements in Non–Small Cell Lung Carcinoma: A 4.5-Year Experience Highlighting Challenges and Pitfalls (2023)
-
Identification of molecular biomarkers associated with non-small-cell lung carcinoma (NSCLC) using whole-exome sequencing (2023)
-
Fertility and pregnancy in chronic myeloid leukemia: real-world experience from an Indian tertiary care institution (2023)
-
A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG) (2023)
Collaboration Network
Top Collaborators
Lalit Kumar
DR. B.R.A. Institute Rotary Cancer Hospital (IN)
15 shared publications
- Development of National Cancer Database for Cost and Quality of Life (CaDCQoL) in India: a protocol
- Pazopanib based oral metronomic therapy for platinum resistant/refractory epithelial ovarian cancer: A phase II, open label, randomized, controlled trial
- Multiple Myeloma: Impact of Time to Transplant on the Outcome
- Multiple Myeloma: Risk Adapted Use of Plerixafor for Stem Cell Mobilization Prior to Autologous Stem Cell Transplantation is Effective and Cost Efficient
- Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women
Showing 5 of 15 shared publications
Deepali Jain
All India Institute of Medical Sciences (IN)
13 shared publications
- Assessment of Brain Metastasis at Diagnosis in Non–Small-Cell Lung Cancer: A Prospective Observational Study From North India
- EGFR mutation testing on plasma and urine samples: A pilot study evaluating the value of liquid biopsy in lung cancer diagnosis and management
- Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review
- Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non–small cell lung carcinoma
- A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
Showing 5 of 13 shared publications
Sachin Khurana
All India Institute of Medical Sciences (IN)
12 shared publications
- Assessment of Brain Metastasis at Diagnosis in Non–Small-Cell Lung Cancer: A Prospective Observational Study From North India
- Pazopanib based oral metronomic therapy for platinum resistant/refractory epithelial ovarian cancer: A phase II, open label, randomized, controlled trial
- A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
- Early-Stage epithelial ovarian cancer: Predictors of survival
- An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of Pemetrexed-Carboplatin versus (Weekly) Paclitaxel-Carboplatin as First-Line Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer
Showing 5 of 12 shared publications
Aruna Nambirajan
All India Institute of Medical Sciences (IN)
11 shared publications
- EGFR mutation testing on plasma and urine samples: A pilot study evaluating the value of liquid biopsy in lung cancer diagnosis and management
- Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review
- Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non–small cell lung carcinoma
- Mapping the immune landscape in small cell lung cancer by analysing expression of immuno-modulators in tissue biopsies and paired blood samples
- Retrospective application of WHO reporting system for lung cytopathology with assessment of risk of malignancy
Showing 5 of 11 shared publications
Anant Mohan
All India Institute of Medical Sciences (IN)
11 shared publications
- Lung Cancer in India
- Analysis of miR-375-3p, miR-197-3p, and miR-15a-5p Expression and Their Clinical Relevance as Biomarkers in Lung Cancer
- EGFR mutation testing on plasma and urine samples: A pilot study evaluating the value of liquid biopsy in lung cancer diagnosis and management
- Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non–small cell lung carcinoma
- Identification of molecular biomarkers associated with non-small-cell lung carcinoma (NSCLC) using whole-exome sequencing
Showing 5 of 11 shared publications
Deepam Pushpam
All India Institute of Medical Sciences (IN)
10 shared publications
- Assessment of Brain Metastasis at Diagnosis in Non–Small-Cell Lung Cancer: A Prospective Observational Study From North India
- A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
- Concurrent hypoxia and apoptosis imparts immune programming potential in mesenchymal stem cells: Lesson from acute graft-versus-host-disease model
- Randomized double-blind, placebo-controlled study of oral gabapentin for prevention of neuropathy in patients receiving paclitaxel
- Young Onset Lung Cancer in India: Insights Into Clinical, Demographic, and Genomic Profiles
Showing 5 of 10 shared publications
Sanjay Thulkar
Sanno University (JP)
7 shared publications
- EGFR mutation testing on plasma and urine samples: A pilot study evaluating the value of liquid biopsy in lung cancer diagnosis and management
- Multiple Myeloma: Impact of Time to Transplant on the Outcome
- Autologous stem cell transplant for multiple myeloma: Impact of melphalan dose on the transplant outcome
- Poems syndrome: consolidation with autologous stem cell transplantation
- Central nervous system metastasis from epithelial ovarian cancer- predictors of outcome
Showing 5 of 7 shared publications
Atul Sharma
All India Institute of Medical Sciences (IN)
7 shared publications
- Assessment of Brain Metastasis at Diagnosis in Non–Small-Cell Lung Cancer: A Prospective Observational Study From North India
- Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial
- Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial
- SMART-ESAS: Smartphone Monitoring and Assessment in Real Time of Edmonton Symptom Assessment System Scores for Patients With Cancer
- Characteristics & outcomes of cancer patients with COVID-19: A multicentre retrospective study from India
Showing 5 of 7 shared publications
Ranjit Kumar Sahoo
All India Institute of Medical Sciences (IN)
7 shared publications
- Multiple Myeloma: Impact of Time to Transplant on the Outcome
- Multiple Myeloma: Risk Adapted Use of Plerixafor for Stem Cell Mobilization Prior to Autologous Stem Cell Transplantation is Effective and Cost Efficient
- Autologous stem cell transplant for multiple myeloma: Impact of melphalan dose on the transplant outcome
- Bendamustine in combination with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: A phase II trial
- Fertility and pregnancy in chronic myeloid leukemia: real-world experience from an Indian tertiary care institution
Showing 5 of 7 shared publications
Raja Pramanik
All India Institute of Medical Sciences (IN)
6 shared publications
- Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial
- Multiple Myeloma: Risk Adapted Use of Plerixafor for Stem Cell Mobilization Prior to Autologous Stem Cell Transplantation is Effective and Cost Efficient
- Concurrent hypoxia and apoptosis imparts immune programming potential in mesenchymal stem cells: Lesson from acute graft-versus-host-disease model
- SMART-ESAS: Smartphone Monitoring and Assessment in Real Time of Edmonton Symptom Assessment System Scores for Patients With Cancer
- Comprehensive Germline Genomic Profiling of Patients with Ovarian Cancer: A Cross-Sectional Study
Showing 5 of 6 shared publications
Sachin Kumar
All India Institute of Medical Sciences (IN)
6 shared publications
- Analysis of miR-375-3p, miR-197-3p, and miR-15a-5p Expression and Their Clinical Relevance as Biomarkers in Lung Cancer
- A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
- Rapid immunomagnetic co-capture assay for quantification of lung cancer associated exosomes
- RNA profile of immuno‐magnetically enriched lung cancer associated exosomes isolated from clinical samples
- Evaluation of the programmed death-ligand 1 mRNA expression and immunopositivity and their correlation with survival outcomes in Indian lung cancer patients
Showing 5 of 6 shared publications
Varsha Singh
All India Institute of Medical Sciences (IN)
5 shared publications
- EGFR mutation testing on plasma and urine samples: A pilot study evaluating the value of liquid biopsy in lung cancer diagnosis and management
- Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non–small cell lung carcinoma
- A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
- Identification of molecular biomarkers associated with non-small-cell lung carcinoma (NSCLC) using whole-exome sequencing
- P59.27 Complementary Utility of Combined ALK/ROS1 FISH with Immunohistochemistry for ALK/ROS1 Rearrangement Testing in Lung Cancer
Sushmita Pathy
5 shared publications
- Assessment of Brain Metastasis at Diagnosis in Non–Small-Cell Lung Cancer: A Prospective Observational Study From North India
- An Open-Label Randomized Controlled Trial Comparing the Efficacy and Safety of Pemetrexed-Carboplatin versus (Weekly) Paclitaxel-Carboplatin as First-Line Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer
- Young Onset Lung Cancer in India: Insights Into Clinical, Demographic, and Genomic Profiles
- Dose-dense Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy for Stage IIB/IIIA Non-small Cell Lung Cancer – A Phase II trial
- Improving the performance status in advanced non-small cell lung cancer patients with chemotherapy (ImPACt trial): a phase 2 study
Sunil Kumar
All India Institute of Medical Sciences (IN)
5 shared publications
- Analysis of miR-375-3p, miR-197-3p, and miR-15a-5p Expression and Their Clinical Relevance as Biomarkers in Lung Cancer
- Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review
- Identification of molecular biomarkers associated with non-small-cell lung carcinoma (NSCLC) using whole-exome sequencing
- Dose-dense Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy for Stage IIB/IIIA Non-small Cell Lung Cancer – A Phase II trial
- Evaluation of the programmed death-ligand 1 mRNA expression and immunopositivity and their correlation with survival outcomes in Indian lung cancer patients
Ishaan Gupta
Indian Institute of Technology Delhi (IN)
5 shared publications
- Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial
- Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection: A multi-center case-control study from India
- Integrating Artificial Intelligence-Driven Wearable Technology in Oncology Decision-Making: A Narrative Review
- Severity and mortality prediction models to triage Indian COVID-19 patients
- Young Onset Lung Cancer in India: Insights Into Clinical, Demographic, and Genomic Profiles
Similar Researchers
Based on overlapping research topics
Manuel Heredia
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Health disparities and outcomes
Cancer Treatment and Pharmacology
Martlin Emeasoba
University of Arkansas at Fayetteville
Lung Cancer Diagnosis and Treatment
Cancer-related molecular mechanisms research
Health disparities and outcomes
K Ellis
University of Arkansas – Fort Smith
Cancer-related molecular mechanisms research
Health disparities and outcomes
Cancer Treatment and Pharmacology
Vijay Patel
University of Arkansas for Medical Sciences
Lung Cancer Diagnosis and Treatment
Cancer-related molecular mechanisms research
Cancer Treatment and Pharmacology
Sajjad Akbar Bhatti
University of Arkansas for Medical Sciences
Lung Cancer Diagnosis and Treatment
Health disparities and outcomes
Cancer Treatment and Pharmacology
Noemi Garcia Garcia
University of Arkansas for Medical Sciences
Lung Cancer Diagnosis and Treatment
Cancer-related molecular mechanisms research
Cancer Treatment and Pharmacology